Sign in
CompletedPhase 2

Midodrine Effect on the Mortality Rates in Septic Shock Patients

Key facts

Who runs it
Noha Mansour
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 2
People taking part
100 people enrolled
Started
7 Nov 2022
Ended
24 Jan 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Midodrine Oral Tablet
Record updated
3 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adult aged 18 years or older diagnosed with septic shock
  • Hypotensive and require IV vasopressor for more than 24 hours

Who cannot take part

  • Unable to administer an oral medication
  • Known allergy to midodrine
  • Severe organic heart disease (ejection fraction <30 percent)
  • Chronic kidney disease (serum creatinine >2mg/dl)
  • Hypovolemic shock
  • Bradycardia (HR<50 b/m)
  • Thyrotoxicosis
  • Pheochromocytoma

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Assessing the safety and efficacy of the adjunctive use of midodrine as a vasopressor in septic shock patients by measuring the difference in the mortality rates between control and intervention groups.

The 2 groups in the trial

  • ControlPlacebo, for comparison

    Will receive IV vasopressor infusion only

    Treatment: Midodrine Oral Tablet

  • MidodrineExisting treatment, for comparison

    Will receive oral midodrine 10 mg/ 8 hours in addition to IV vasopressor infusion till the end of treatment (subject remaining vasopressor-free for 24 consecutive hours).

    Treatment: Midodrine Oral Tablet

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Study Evaluating the Efficacy and Safety of Adjunctive Use of Midodrine in Septic Shock Patients
Publications
Record updated
3 March 2025